MoneyWorks4Me

Dr. Reddys Laboratories informs about press release

28 Oct 2020 Evaluate

Dr. Reddys Laboratories has informed that it has enclosed a Press Release in term of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on 28 October 2020 titled ‘Dr. Reddy's Laboratories announces appointment of new Chief Financial Officer’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..